![]() BC-DXI-843 structure
|
Common Name | BC-DXI-843 | ||
---|---|---|---|---|
CAS Number | 2421117-98-6 | Molecular Weight | 546.660 | |
Density | 1.4±0.1 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C28H26N4O4S2 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of BC-DXI-843BC-DXI-843 is a potent and specific AIMP2-DX2 inhibitor with an IC50 of 0.92 μM, more than 100-fold selectivity over AIMP2 (IC50 >100 μM) in a luciferase assay. BC-DXI-843 acts as a promising lead targeting AIMP2-DX2 in lung cancer. |
Name | N-[4-(4-Methoxyphenyl)-1,3-thiazol-2-yl]-Nα-[(4-methylphenyl)sulfonyl]-L-tryptophanamide |
---|---|
Synonym | More Synonyms |
Density | 1.4±0.1 g/cm3 |
---|---|
Molecular Formula | C28H26N4O4S2 |
Molecular Weight | 546.660 |
Exact Mass | 546.139526 |
LogP | 5.89 |
Index of Refraction | 1.679 |
N-[4-(4-Methoxyphenyl)-1,3-thiazol-2-yl]-Nα-[(4-methylphenyl)sulfonyl]-L-tryptophanamide |
1H-Indole-3-propanamide, N-[4-(4-methoxyphenyl)-2-thiazolyl]-α-[[(4-methylphenyl)sulfonyl]amino]-, (αS)- |